Market Tracker

08/24 2:09pm ET

Derma Sciences Inc (NASDAQ:DSCI)

5.01
Delayed Data
As of 1:53pm ET
 -0.03 / -0.60%
Today’s Change
2.85
Today|||52-Week Range
6.81
+9.63%
Year-to-Date
LabCorp Q2 Results Strong, Sequenom Buyout Raises Hope
Aug 19 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for August 11th
Aug 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.04
Today’s open5.03
Day’s range4.95 - 5.03
Volume45,427
Average volume (3 months)47,554
Market cap$142.7M
Dividend yield--
Data as of 1:53pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)+8.64%
Earnings growth (this year)+97.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+0.87%
P/E ratioNM
Price/Sales1.39
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
SIENSientra Inc+0.03+0.37%
EYESSecond Sight Medical...-0.11-2.99%
RTIXRTI Surgical Inc+0.00+0.15%
EDAPEdap Tms SA0.000.00%
Data as of 2:08pm ET, 08/24/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$84.5M
Annual profit (last year)-$38.1M
Net profit margin-24.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Executive Chairman &
Chief Executive Officer
Stephen T. Wills
Executive Vice President-
Operations
Frederic Eigner
Corporate headquarters
Princeton, New Jersey

Forecasts